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 Implication for health policy/practice/research/medical education:
Whiplash associated disorders are very costly to any healthcare structure, whatever the policy that shapes it. The prevalence of 
cervicogenic headache in whiplash injuries are as high as 53%.
1. Background
The term cervicogenic headache (CEH) was first coined 
by Sjaastad et al. in 1983. In 1990 the CHISG criteria (cer-
vicogenic headache international study group) for CEH 
was issued (1). Whiplash injuries were later implicated as 
likely triggers of CEH (1). Whiplash-associated disorders 
Background: Whiplash patients regard cervicogenic headache (CEH) as the most burden-
some symptom of their condition. Sufferers experience a significant degree of disability 
from headache, associated neck pain and disability, and sleep disturbance. Lateral C1/2 
joint pulsed radiofrequency (PRF) treatment has been shown to produce significant relief 
from headache in patients with CEH.
Objectives: The objective of this retrospective questionnaire study of 45 consecutive whip-
lash patients with CEH who had undergone antero-lateral atlantoaxial joint pulsed radio-
frequency treatment (AA PRF) was to evaluate the treatment’s long-term effects on pain-
related disability and health-related quality of life.
Patients and Methods: Four questionnaires were sent to all 45 patients who had undergone AA PRF: 
1) The short form-36 (SF-36); 2) The neck disability index (NDI); 3) The medical outcome 
scale-sleep scale (MOS-SS); 4) The headache impact test-6 (HIT-6).
All 45 patients received AA PRF under fluoroscopic guidance. PRF treatment was conducted 
at 45 V with a pulsed frequency of 4 Hz and a pulsed width of 10 ms for 4 minutes .
Results: Patients who responded to the procedure reported lower pain scores at 2, 6, and 
12 months of follow-up compared to nonresponders. More important, patients reported 
marked improvements in headache impact (P < 0.01), neck-disability scores (P < 0.01), 
awakening due to headache (P < 0.01), and sleep problems (9-item; P < 0.05) on the MOS-SS. 
Responders to the procedure also reported a significantly higher health-related quality of 
life in terms of  bodily pain (P < 0.05) and health change (P < 0.01) on the SF-36.
Conclusions: In light of the inherent limitations of our retrospective study, AA PRF treat-
ment can only be tentatively viewed as a promising treatment modality for whiplash pa-
tients with CEH and is subject to validation in future studies.
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(WAD) are very costly to society, and patients have rated 
headaches as the most burdensome WAD (2).
The prevalence of CEH had been estimated as high as 
4.1% in the general population and as high as 17.5% among 
patients with severe headaches. For patients with head-
aches after whiplash, the prevalence is as high as 53% (3-
5).
Most CEH sufferers experience a significant degree 
of disability from headache, associated neck pain, and 
sleep disturbance. It is often the disability emanating 
from CEH attacks that compromises quality of life for 
these patients. Currently, no drugs are effective for CEH. A 
randomized controlled study showed that manual ther-
apy alone was no more effective than exercise alone (6, 
7). Lateral C1/2 joint injections have identified the lateral 
C1/2 joint as a source of pain in patients with CEH (8, 9). 
Narouze et al. (10) found that 25% of their patients expe-
rienced 50% pain relief within 3 months. In a retrospec-
tive study with 86 patients, pulsed radiofrequency (PRF) 
application on the antero-lateral C1/2 joint (AA PRF) pro-
duced long-term pain relief up to 6 months, with more 
than 50% of patients experiencing pain relief of more 
than 50% (11).
Using cervical zygapophysial joint pain as a model for 
chronic neck pain, Wallis and colleagues showed that all 
patients who obtained complete pain relief exhibited 
resolution of their preoperative psychological distress, 
whereas those who were unrelieved continued to dem-
onstrate signs of psychological distress (12).
2. Objectives
This retrospective questionnaire study of 45 WAD pa-
tients with CEH who had undergone antero-lateral C1/2 
joint PRF application (AA PRF) more than 1 year ago 
aimed to evaluate its AA PRF’s effects on pain-related dis-
ability and health-related quality of life.
3. Patients and Methods
Institutional review board approval was obtained prior 
to administering the questionnaire to all patients. This 
retrospective questionnaire study included 45 consecu-
tive whiplash patients who had undergone lateral C1/2 
joint PRF application for CEH in a single pain center in 
the Netherlands between January 2007 and February 
2009. The patients were recruited from a review of the 
pain center’s procedure records and verified with the 
individual patient’s medical records. All 45 patients who 
had fulfilled clinical criteria specified in Box, had under-
gone cervical facet denervation (C3 to C5) prior to the 
antero-lateral C1/2 PRF with minimal improvement. The 
lateral C1/2 joints in these 45 patients were found to be ex-
tremely tender, even after cervical facet denervation. All 
45 patients were sent four questionnaires that included 
the Short Form-36 (SF-36) (13), neck disability index (NDI) 
(14), the medical outcome scale-sleep scale (MOS-SS) (15), 
and the headache impact test-6 (HIT-6) (16). All four ques-
tionnaires have been established for reliability and va-
lidity in the Dutch population (17-20). The patients were 
also sent a general personal data form that included a 
dichotomous question of whether they had experienced 
more than 50% pain relief after receiving the lateral C1/2 
joint (AA PRF) injection. After all questionnaires were re-
turned, post-AA PRF progress was evaluated by retrospec-
tively retrieving pain scores (numerical rating scale of 0 
to 10) of all 45 patients from individual case files. The NRS 
scores were retrieved at 2, 6, and 12 months. These data 
were all collected by an assistant not involved in the de-
sign of the study or in the analysis of the data. 
The technical details of the percutaneous procedure 
have been described elsewhere (11). A 22-G, 45-mm insu-
lated radiofrequency needle with a 5-mm active tip was 
introduced percutaneously, under fluoroscopic control, 
so that it entered the lateral 1/3 of the of the antero-lateral 
C1/2 joint (Figure 1). Guided by fluoroscopy, it is important 
that the noninsulated needle tip does not contact either 
intra-articular osseous surface of the lateral C1/2 joint. 
This is to avoid causing the patient unnecessary pain 
during sensory stimulation. With the active tip within 
the intra-articular space, sensory stimulation at 50 Hz 
up to 1.0 V and motor stimulation at 2 Hz up to 1.0 V is 
almost always negative. PRF application at 45 V was then 
initiated with a pulse frequency of 4 Hz, pulse duration 
of 10 ms for 4 minutes . We do not routinely give contrast, 
local anesthetic, or steroids either before or after the PRF 
application.
For the analysis of the MOS sleep scale, 90% comple-
tion of a section was considered sufficient for analysis. 
The HIT-6 and NDI scores were excluded if one item was 
missing. For the SF-36 subscale scores, missing values 
Clinical Criteria for Cervicogenic Headache Attributable to Whiplash Injury
1 Predominantly unilateral headache without side-shift
2 Symptoms and signs of neck involvement: pain triggered by neck movement or external pressure of the posterior neck or occipi-
tal region; ipsilateral neck, shoulder, and arm pain; reduced range of motion.
3 Pain episodes of varying duration or fluctuating continuous pain
4 Moderate, non-excruciating pain, usually of a non-throbbing nature
5 Whiplash injury sustained prior to onset of headache with no obvious neurological deficit (Grade II Quebac Task Force classifica-
tion)
6 No direct head injury or any loss of consciousness
Box. Clinical Criteria Used in Our Center for the Diagnosis of CE Attributable to Whiplash Injury
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were substituted with group mean values in accordance 
with the instructions in the SF-36 manual. All statistics 
were performed using SPSS (version 16.0 for Windows). 
Descriptive statistics were generally reported as mean 
values ± 1 standard deviation (SD) and were analyzed for 
their degree of skewness or kurtosis. A student’s t-test 
(continuous variables) and Chi-square test (for dichoto-
mous variables) were used to compare the differences 
in baseline characteristics and study measures between 
both groups. Pearson’s correlation coefficients were 
used to evaluate the correlation between questionnaire 
scores and their relevant domains. A significance level of 
P < 0.05 was used for all tests.
4. Results
Thirty-six patients returned their questionnaires with-
in 4 weeks. We attempted to contact the remaining 9 
patients. Four patients returned their questionnaires 
after 2 reminders (88.9%). We were unable to contact 1 
patient. One patient agreed to the HIT-6 over the phone 
but not the rest of the questionnaires. Three patients 
agreed to the use of retrospective data but not to the 
questionnaires. Forty patients completed the SF-36 and 
NDI questionnaires, 39 patients completed the MOS-SS 
questionnaires, while 41 patients completed the HIT-6 
questionnaires. Of the 44 patients who consented to the 
study, 25 patients self-reported more than 50% pain relief 
at the time of the survey and were denoted as treatment 
responders (hereafter, responders). The remaining 19 pa-
tients reported less than 50% pain relief at the time of the 
survey and were denoted as treatment nonresponders 
(hereafter, nonresponders). The responders’ post-AA PRF 
improvement in pain scores was consistently lower than 
the scores of the nonresponders at 2, 6, and 12 months 
(Table 1; P < 0.05). The baseline demographic character-
istics of the responders and nonresponders did not dif-
fer significantly (Table 2). Additionally, the history of 
postprocedure employment, litigation, and government 
benefits did not differ either; the only demographic char-
acteristic that did vary significantly was the age of the re-
sponders (t = -1.95, P < 0.058). 
The mean questionnaire scores (± SD) of both the re-
sponder and the nonresponder group are shown in 
Table 1. The HIT-6 and the NDI scores were significantly 
lower in the responder group than in the nonresponder 
group. The domains of awakening due to headache sleep 
problems Index I (6-items) and sleep problems Index II 
(9-items) in the MOS-SS were all significantly lower in the 
responder group than in the nonresponder group. Re-
sponders also had higher mean scores in all domains of 
the SF-36 (Table 1). However, this achieved statistical signif-
icance in only 2 subscales: bodily pain (t = -2.44, P < 0.05) 
and perception of health change (t = -3.60, P < 0.01), with 
role-physical being nonsignificant (t = -1.88, P = 0.68).
The lower headache impact scores in the responder 
group correlated significantly with a decrease in neck 
disability (r = 0.64, P < 0.001) as well as with awakening 
due to headache (r = 0.55, P < 0.01) in the MOS-SS. The 
lower neck-disability score in the responder group also 
correlated significantly with a decrease in sleep prob-
lems and awakening due to headache (6-item: r = 0.36, 
P < 0.05; 9-item: r = 0.44, P < 0.01) in the MOS-SS. The 
Figure 1. Lateral View With a 5º Oblique Tilt for Initial Needle Entry (Left). Postero-Anterior View (Right) of Needle Entry into Lateral C1/2 Joint. Notice the 
Active Tip Does Not Contact the Intra-Articular Osseous Surface.
Chua NHL et al.
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Responder Group, (n = 25) Non-Responder Group, (n = 19) t score P value
HIT-6 a, Mean ± SD 56.7 ± 11.7 68.6 ± 7.1 4.02 < 0.001 b
NDI a, Mean ± SD 18.9 ± 8.4 27.1 ± 7.4 3.27 0.002 b
MOS-SS a, Mean ± SD
Sleep disturbance
Snoring
Headache
Sleep adequacy
Somnolence
Sleep problems index I
Sleep problems index II
44.8 ± 24.9
42.9 ± 28.5
44.5 ± 30.2
43.2 ± 28.7
35.8 ± 25.9
41.2 ± 10.4
42.5 ± 13.2
55.3 ± 25.3
29.4 ± 33.3
72.9 ± 28.2
32.4 ± 27.0
46.7 ± 20.7
48.2 ± 9.1
51.1 ± 10.7
1.30
-1.32
3.02
-1.21
1.46
2.25
2.24
0.203
0.196
0.005 b
0.235
0.152
0.030 b
0.031 b
SF-36, Mean ± SD
Physical functioning
Role-physical
Bodily pain
General health
63.9 ± 23.9
37.0 ± 43.2
55.8 ± 23.0
53.3 ± 23.3
57.4 ± 18.2
16.2 ± 26.4
41.1 ± 15.3
49.7 ± 21.8
-0.98
-1.88
-2.44
-0.50
0.331
0.068
0.020 b
0.623
Vitality, Mean ± SD 46.5 ± 21.8 42.4 ± 17.0 -0.68 0.500
Social functioning, Mean ± SD 61.4 ± 25.3 57.4 ± 16.0 -0.62 0.538
Role-emotional, Mean ± SD 76.8 ± 38.2 58.3 ± 41.3 -1.42 0.166
Mental health, Mean ± SD 70.3 ± 20.6 64.7 ± 18.6 -0.89 0.379
Perceived health change, Mean ± SD 65.2 ± 26.9 39.7 ± 17.8 -3.60 0.001 b
NRS a scores, Mean ± SD
0 month
2 months
6 months
12 months
8.68 ± 0.78
1.64 ± 1.53
1.68 ± 1.89
1.45 ± 1.41
8.32 ± 0.82
6.00 ± 2.85
6.53 ± 2.41
7.74 ± 1.32
1.46
-5.98
-7.08
-14.71
0.153
< 0.001 b
< 0.001 b
< 0.001 b
Table 1. Questionnaire and Pain (NRS) a Scores
a Abbreviations: HIT-6; headache impact test-6; MOS-SS, medical outcome scale-sleep scale; NDI, neck disability index; NRS, numerical rating scale
b Denotes comparisons that are statistically significant at P < 0.05.
Non-Responders, (n = 19) Responders, (n = 25) P value
Age, y, Mean ± SD 41 ± 13 49 ± 11 0.05
Gender, No. 0.68
Male
Female
11
8
16
9
Height, cm, Mean ± SD 174 ± 9 171 ± 7 0.25
Weight, kg, Mean ± SD 73.1 ± 14.5 70.0 ± 15.3 0.81
Secondary education and above, No. 3 7 0.32
Smoke, No. 7 4 0.12
Alcohol, No. 7 10 0.79
Years of pain, Mean ± SD 6.9 ± 9.4 7.1 ± 3.5 0.66
Pre-procedure numeric rating scale (NRS)- score, Mean ± SD 8.4 ± 0.8 8.6 ± 0.8 0.38
Involved in litigation prior to procedure, No. 2 4 0.59
Years post-procedure, Mean ± SD 2.0 ± 0.5 1.7 ± 0.7 0.39
Currently employed, No. 9 10 0.59
Returned to work, No. 10 11 0.82
Benefits act from work loss or injury, No. 7 7 0.52
Table 2. Baseline Characteristics of Treatment Responders and Nonresponders to Antero-Lateral C1/2 Joint PRF a
a Abbreviation: PRF, pulsed radiofrequency
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perceived improvement in health correlated well with a 
reduction in the impact of headaches on life (r = -0.54, P 
= 0.001), neck disability (r = -0.50, P = 0.001), and bodily 
pain (r = 0.67, P < 0.001). 
5. Discussion
From our retrospective findings, patients with sus-
tained pain relief after AA PRF experienced improve-
ments in headaches’ impact on life, reductions in neck 
disability, improvements with respect to sleep problems, 
and an improved overall perception of health within 
12 months after treatment. The improvements in head-
aches’ impact on life were also highly correlated with im-
provements in neck disability and sleep. The divergent 
pain scores between the responders and nonresponders 
at 2, 6, and 12 months after AA PRF were reinforced by a 
self-reported improvement in general health by the re-
sponders. Despite consistently higher scores in all the 
health-related, quality-of-life domains, we were limited 
by a relatively small sample size to detect significant im-
provements in those who responded to AA PRF. We are 
unable to conclude that the extended duration of pain 
relief observed in the responder group is entirely a result 
of antero-lateral C1/2 joint PRF due to inherent limita-
tions in our retrospective study. However, our findings 
suggest that if whiplash patients with CEH do respond 
to intra-articular lateral C1/2 joint PRF, they may not only 
improve in terms of pain scores but also may exhibit pos-
itive changes to life burdens, neck-related disability, and 
perceived health over the long term.
An extensive body of research is looking at the mecha-
nisms through which PRF acts. At the time of this writ-
ing, most studies point towards an alteration in synap-
tic transmission in a neuromodulatory-type effect (21, 
22). The effects of PRF were initially postulated to be via 
a combination of excitatory C-fibre response suppres-
sion as well as inhibition of synaptic transmission with 
the decrease in excitatory postsynaptic potential (22-24). 
However, in intra-articular PRF, this is unlikely to be the 
case: the effects of intra-articular PRF are most likely a 
result of its anti-inflammatory properties. This occurs 
as a result of the attenuation of proinflammatory cyto-
kines such as interleukin (IL)-1b, tumor necrosis factor a 
(TNF-a), and IL-6 by the generated electric fields (25, 26). 
In fact, IL-1b, which is present in high amounts in OA car-
tilage, is considered to be one of the main catabolic fac-
tors involved in the cartilage matrix degradation (27, 28). 
In addition, an up-regulation of adenosine A2a receptor 
density has been observed in human neutrophils treated 
with pulsed electric fields (29). Activation of adenosine 
A2a receptors seems to be associated with inhibition 
of the catabolic cytokines TNF-a, IL-6, and IL-8 (30, 31). It 
seems intuitive to presume a similar mechanism of ac-
tion of the A2a receptor on chondrocyte membranes, 
with a similar consequential effect of cytokine inhibition 
(27, 31).
One of the hypotheses generated from this retrospec-
tive study is thus the chrondro-protective mode of action 
of intra-articular PRF, which may explain the anecdotal 
observation of pain relief 2 to 4 weeks after PRF in a num-
ber of patients. A number of in-vitro studies have shown 
that chondrocyte proliferation and matrix synthesis are 
significantly enhanced by pulsed electrical fields (28, 
32-34). Fini et al. (27) suggest that the delivery of pulsed 
electromagnetic fields combines an anabolic effect on 
chondrocytes, a catabolic cytokine blockage, a stimula-
tory effect on anabolic cytokine production, and a coun-
teraction of the inflammatory process in osteoarthritis. 
Cosman et al. (35) assert that magnetic fields generated 
in PRF are negligible and any therapeutic effects are due 
to the electric fields. More research will therefore be re-
quired to verify in-vitro effects, if this hypothesized chon-
dro-protective mechanism is indeed true. 
The main limitation of our study is the lack of a control 
group. The retrospective nature of the study and the rela-
tively small sample size also prevent strong conclusions 
regarding the efficacy of antero-lateral C1/2 PRF for whip-
lash patients with CEH. 
As we attempt to prospectively evaluate our results in a 
formal trial, more studies will be also needed to evaluate 
other treatment modalities in this multifaceted clinical 
diagnosis. It seems prudent to adopt an algorithmic ap-
proach in the management of such patients, and at the 
time of this writing, antero-lateral C1/2 joint PRF should 
be at most be regarded as a potentially viable treatment 
modality subject to validation in future studies.
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